Synapse - Charlotte Ariyan

Results (40)

A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors

Journal Article

Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
Radiotherapy and Oncology (2024)

Fulltext@MSK | Save

A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts

Meeting Abstract

Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

ASO Visual Abstract: Assessment of frailty can guide decision making for utilization of sentinel lymph node biopsy in patients with thick melanoma

Miscellaneous

Sharma, A. S.; Flynn, J. R.; Panageas, K. S.; Shahrokni, A.; Tin, A. L.; Bello, D. M.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.; Bartlett, E. K.
Annals of Surgical Oncology (2021)

Fulltext@MSK | Save

Assessment of frailty can guide decision making for utilization of sentinel lymph node biopsy in patients with thick melanoma

Journal Article

Sharma, A. S.; Flynn, J. R.; Panageas, K. S.; Shahrokni, A.; Tin, A. L.; Bello, D. M.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.; Bartlett, E. K.
Annals of Surgical Oncology (2021)

Fulltext@MSK | Save

Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas

Journal Article

Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Journal Article

Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
Nature Communications (2021)

Fulltext@MSK | Save

PD-1 blockade in advanced adrenocortical carcinoma

Meeting Abstract

Raj, N.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J.; Do, R.; Capanu, M.; Zamarin, D.; Saltz, L.; Ariyan, C.; more...
Pancreas (2020)

Fulltext@MSK | Save

Response to checkpoint blockade and survival in patients with stage III melanoma

Meeting Abstract

Theriot, J.; Bello, D.; Lobaugh, S.; Bartlett, E. K.; Betof, A.; Shoushtari, A.; Postow, M.; Callahan, M.; Brady, M. S.; Wong, R.; more...
Annals of Surgical Oncology (2020)

Fulltext@MSK | Save

Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial